L. Attala

An explainable model of host genetic interactions linked to COVID-19 severity

G. Parati, A. d’Arminio Monforte, F. Chiaromonte, 2021, Communications Biology.

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)

D. Francisci, F. Vichi, P. Pierotti, 2021, Journal of Infection.

Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment.

N. Pimpinelli, M. Matucci Cerinic, A. Bartoloni, 2013, The Journal of infection.

Latent tuberculosis infection in psoriasis and other dermatological immunomediated diseases: a combined approach by QuantiFERON®‐TB Gold and tuberculin skin tests

A. Bartoloni, F. Bartalesi, F. Ricceri, 2014, International journal of dermatology.

Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder

G. Parati, R. Scala, M. Girardis, 2023, Respiratory Research.

Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.

G. Rossolini, A. Bartoloni, P. Pecile, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir

E. Ricci, G. Cenderello, K. Falasca, 2023, PloS one.

An explainable model of host genetic interactions linked to COVID-19 severity

A. d’Arminio Monforte, M. L. La Rovere, M. Colaneri, 2022, Communications Biology.